Pain Management Market: By Type, By Pain Management Devices ), By Condition, By Distribution Channel, By Seviority and Region Forecast 2020-2031
Pain Management Market size was valued at US$ 43.2 billion in 2024 and is expected to reach US$ 77.0 billion by 2031, growing at a significant CAGR of 8.6% from 2025-2031. Pain management is caused by the intense damage of the tissue or any other illness. Pain may be the result of injury or different diseases such as diabetic neuropathy, arthritis, osteoarthritis, sclerosis, cancer, fibromyalgia or others. The management of the pain is based on the severity and type of the pain. Pain can be classified into two types based on intensity, acute and chronic. Acute pain is a sudden onset of pain whereas chronic pain is persistent, usually due to ageing. There were many pain management solutions available in the market in the form of drugs, devices and therapies.
The global healthcare system has been influenced by the COVID-19 epidemic. Health officials are working to stop the spread of the coronavirus by enforcing lockdown rules, and most elective and non-urgent surgeries have been postponed around the world. As per the research article published in the Indian Journal of Anaesthesia 2020, COVID-19 hurts pain clinics, including interventional pain management procedures. The Indian Society of Anaesthesiologists also released recommendations on anaesthesia and intensive care techniques.
Study Period
2025-2031Base Year
2024CAGR
8.6%Largest Market
Asia-PacificFastest Growing Market
North-America
Huge number of factors such as advancements in the pain management techniques such as Neurostimulation devices, increase in ageing population, and established reimbursement scenario are projected to boost the market growth over the forecast period. In addition, high rates of trauma conditions, incidence of the chronic diseases such as arthritis, and cancer expected to bolster the market growth over the forecast period. However, low awareness among the patient pool regarding the availability of low invasive pain management techniques and alternative treatment methods are expected to hamper the market growth over the forecast period.
Geographically, global pain management market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America pain management market projected to have the significant growth rate owing to rise in the number of surgeries, increase in the number of patients suffering with pain and favorable reimbursement policies. Europe pain management market is expected to grow at notable rates owing to the presence of key market players, ageing population, and development of new pain management treatment options for different conditions. Asia Pacific market is projected to have lucrative opportunity of growth owing to the factors such as presence of large patient pool and untapped markets in developing and under developing regions. Development of healthcare infrastructure and public spending on health in countries such as India and China expected to show notable growth rate in the region. For instance, in October 2013, DJO Global has announced that it is planning to launch the 10 pain management devices in India in coming years.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 43.2 billion |
|
Market Size in 2031 |
US$ 77.0 billion |
|
Market CAGR |
8.6% |
|
By Type |
|
|
By Condition |
|
|
By Distribution Channel |
|
|
By Seveority |
|
|
By Region |
|
Download Free Sample Report
The pain management market size was valued at US$ 43.2 billion in 2024 and is expected to reach US$ 77.0 billion by 2031, growing at a significant CAGR of 8.6% from 2025-2031
The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The market key players are Medtronic Plc (Ireland), DJO Global Inc. (U.S.), GlaxoSmithKline Plc (U.K.), Johnson and Johnson (U.S.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel)
| 1. Executive Summary |
| 2. Global Pain Management Market Introduction |
| 2.1.Global Pain Management Market - Taxonomy |
| 2.2.Global Pain Management Market - Definitions |
| 2.2.1.Type |
| 2.2.2.Condition |
| 2.2.3.Distribution Channel |
| 2.2.4.Seveority |
| 2.2.5.Region |
| 3. Global Pain Management Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID-19 on Market |
| 4. Global Pain Management Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Pain Management Market By Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Pain Management Drug |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Pain Management Devices |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Others |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Pain Management Market By Condition, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Cancer Pain |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Musculoskeletal Pain |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Neuropathic Pain |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Migraine & Facial Pain |
| 6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Pain Management Market By Distribution Channel, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Clinics |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Global Pain Management Market By Severity, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. Chronic Pain |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Acute Pain |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 9. Global Pain Management Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10. North America Pain Management Market, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Pain Managements Drug |
| 10.1.2.Pain Management Devices |
| 10.1.3.Others |
| 10.2. Condition Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Cancer Pain |
| 10.2.2.Musculoskeletal Pain |
| 10.2.3.Neuropathic Pain |
| 10.2.4.Migraine & Facial Pain |
| 10.2.5.Others |
| 10.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Clinics |
| 10.3.3.Others |
| 10.4. Seveority Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Chronic Pain |
| 10.4.2.Acute Pain |
| 10.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Pain Management Market, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Pain Managements Drug |
| 11.1.2.Pain Management Devices |
| 11.1.3.Others |
| 11.2. Condition Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Cancer Pain |
| 11.2.2.Musculoskeletal Pain |
| 11.2.3.Neuropathic Pain |
| 11.2.4.Migraine & Facial Pain |
| 11.2.5.Others |
| 11.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Clinics |
| 11.3.3.Others |
| 11.4. Seveority Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Chronic Pain |
| 11.4.2.Acute Pain |
| 11.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12.Asia Pacific (APAC) Pain Management Market, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Pain Managements Drug |
| 12.1.2.Pain Management Devices |
| 12.1.3.Others |
| 12.2. Condition Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Cancer Pain |
| 12.2.2.Musculoskeletal Pain |
| 12.2.3.Neuropathic Pain |
| 12.2.4.Migraine & Facial Pain |
| 12.2.5.Others |
| 12.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Clinics |
| 12.3.3.Others |
| 12.4. Seveority Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Chronic Pain |
| 12.4.2.Acute Pain |
| 12.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Pain Management Market, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Pain Managements Drug |
| 13.1.2.Pain Management Devices |
| 13.1.3.Others |
| 13.2. Condition Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Cancer Pain |
| 13.2.2.Musculoskeletal Pain |
| 13.2.3.Neuropathic Pain |
| 13.2.4.Migraine & Facial Pain |
| 13.2.5.Others |
| 13.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Clinics |
| 13.3.3.Others |
| 13.4. Seveority Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Chronic Pain |
| 13.4.2.Acute Pain |
| 13.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Pain Management Market, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 14.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Pain Managements Drug |
| 14.1.2.Pain Management Devices |
| 14.1.3.Others |
| 14.2. Condition Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Cancer Pain |
| 14.2.2.Musculoskeletal Pain |
| 14.2.3.Neuropathic Pain |
| 14.2.4.Migraine & Facial Pain |
| 14.2.5.Others |
| 14.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Hospitals |
| 14.3.2.Clinics |
| 14.3.3.Others |
| 14.4. Seveority Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Chronic Pain |
| 14.4.2.Acute Pain |
| 14.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Medtronic Plc (Ireland) |
| 15.2.2.DJO Global Inc. (U.S.) |
| 15.2.3.GlaxoSmithKline Plc (U.K.) |
| 15.2.4.Johnson and Johnson (U.S.) |
| 15.2.5.Novartis AG (Switzerland) |
| 15.2.6.Pfizer Inc. (U.S.) |
| 15.2.7.Teva Pharmaceutical Industries Ltd. (Israel) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
